Ratings by Jefferies (Michael Yee)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/9/2024 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2024 | Kodiak Sciences Inc. | KOD | Maintain | Hold (N/A) |
|
Details | ||
| 3/28/2024 | Moderna | MRNA | Maintain | Hold (N/A) |
|
Details | ||
| 3/28/2024 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2024 | Nuvation Bio Inc | NUVB | Upgrade | Buy (Hold) |
2.25 (2.58) |
14.67% | Details | |
| 3/22/2024 | Cargo Therapeutics | CRGX | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2024 | Immuneering Corporation | IMRX | Downgrade | Hold (Buy) |
2.90 (1.77) |
-38.97% | Details | |
| 3/13/2024 | Morphic Therapeutic | MORF | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2024 | Olema Pharmaceuticals | OLMA | Maintain | Buy (N/A) |
|
Details | ||
| 2/19/2024 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2024 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 2/5/2024 | Amgen | AMGN | Maintain | Buy (Buy) |
|
Details | ||
| 1/26/2024 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2024 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 12/22/2023 | LianBio | LIAN | Downgrade | Hold (Buy) |
4.36 (0.32) |
-92.66% | Details | |
| 12/8/2023 | ALX Oncology | ALXO | Upgrade | Buy (Hold) |
8.43 (15.74) |
86.71% | Details | |
| 12/8/2023 | Beam Therapeutics Inc | BEAM | Downgrade | Hold (Buy) |
28.67 (24.31) |
-15.21% | Details | |
| 12/5/2023 | Cargo Therapeutics | CRGX | New Coverage | Buy (N/A) |
16.29 (19.10) |
17.25% | Details | |
| 11/8/2023 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2023 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 10/25/2023 | Amarin Corporation | AMRN | Downgrade | Hold (Buy) |
0.74 (0.87) |
17.57% | Details | |
| 10/25/2023 | Scholar Rock | SRRK | Upgrade | Buy (Hold) |
7.53 (13.95) |
85.26% | Details | |
| 10/10/2023 | RayzeBio | RYZB | New Coverage | Buy (N/A) |
20.59 (62.49) |
203.5% | Details | |
| 8/14/2023 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2023 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2023 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 7/24/2023 | Kodiak Sciences Inc. | KOD | Downgrade | Hold (Buy) |
7.29 (3.47) |
-52.4% | Details | |
| 7/13/2023 | Scholar Rock | SRRK | Maintain | Hold (N/A) |
|
Details | ||
| 7/7/2023 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2023 | Prometheus Biosciences Inc | RXDX | Downgrade | Hold (Buy) |
194.22 (199.92) |
2.93% | Details | |
| 4/4/2023 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2023 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2023 | Aligos Therapeutics Inc. | ALGS | Upgrade | Buy (Hold) |
0.94 (0.79) |
-15.96% | Details | |
| 1/6/2023 | Nuvation Bio Inc | NUVB | Downgrade | Hold (Buy) |
2.09 (2.58) |
23.44% | Details | |
| 1/6/2023 | Amarin Corporation | AMRN | Upgrade | Buy (Hold) |
1.24 (0.87) |
-29.84% | Details | |
| 12/19/2022 | Moderna | MRNA | Upgrade | Buy (Hold) |
207.25 (102.00) |
-50.78% | Details | |
| 11/30/2022 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2022 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2022 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2022 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 10/25/2022 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 10/17/2022 | Prothena Corp | PRTA | Maintain | Buy (N/A) |
|
Details | ||
| 10/4/2022 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 9/19/2022 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2022 | Ventyx Biosciences Inc | VTYX | Maintain | Buy (N/A) |
|
Details | ||
| 8/31/2022 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 8/31/2022 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 8/23/2022 | Inhibrx Inc. | INBX | Maintain | Buy (N/A) |
|
Details | ||
| 6/15/2022 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2022 | Immunocore Holdings | IMCR | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2022 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/28/2022 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2022 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2022 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2022 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2022 | Ventyx Biosciences Inc | VTYX | Maintain | Buy (Buy) |
|
Details | ||
| 3/17/2022 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2022 | Prothena Corp | PRTA | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2022 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2022 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2022 | Moderna | MRNA | Maintain | Hold (N/A) |
|
Details | ||
| 2/18/2022 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2022 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 2/2/2022 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2022 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2022 | Aligos Therapeutics Inc. | ALGS | Downgrade | Hold (Buy) |
10.61 (0.79) |
-92.55% | Details | |
| 1/4/2022 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 12/22/2021 | Scholar Rock | SRRK | Downgrade | Hold (Buy) |
26.17 (13.95) |
-46.69% | Details | |
| 12/22/2021 | Adagio | ADGI | Downgrade | Hold (Buy) |
10.00 (4.64) |
-53.6% | Details | |
| 12/22/2021 | ALX Oncology | ALXO | Downgrade | Hold (Buy) |
22.52 (15.74) |
-30.11% | Details | |
| 12/15/2021 | Immunocore Holdings | IMCR | Maintain | Buy (N/A) |
|
Details | ||
| 12/14/2021 | Olema Pharmaceuticals | OLMA | Maintain | Buy (N/A) |
|
Details | ||
| 12/1/2021 | Moderna | MRNA | Maintain | Hold (N/A) |
|
Details | ||
| 11/26/2021 | LianBio | LIAN | New Coverage | Buy (N/A) |
14.14 (0.32) |
-97.74% | Details | |
| 11/15/2021 | Ventyx Biosciences Inc | VTYX | New Coverage | Buy (N/A) |
23.07 (4.35) |
-81.14% | Details | |
| 11/5/2021 | Moderna | MRNA | Maintain | Hold (N/A) |
|
Details | ||
| 11/3/2021 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2021 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2021 | Exelixis | EXEL | New Coverage | Buy (N/A) |
21.70 (22.49) |
3.64% | Details | |
| 10/22/2021 | Metacrine Inc. | MTCR | Downgrade | Hold (Buy) |
3.83 (0.49) |
-87.21% | Details | |
| 10/21/2021 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2021 | Moderna | MRNA | Maintain | Hold (N/A) |
|
Details | ||
| 10/13/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 10/8/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 9/23/2021 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 9/22/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 9/10/2021 | Moderna | MRNA | Maintain | Hold (N/A) |
|
Details | ||
| 9/7/2021 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/31/2021 | Moderna | MRNA | Maintain | Hold (N/A) |
|
Details | ||
| 8/31/2021 | Adagio | ADGI | New Coverage | Buy (N/A) |
30.38 (4.64) |
-84.73% | Details | |
| 8/24/2021 | Immuneering Corporation | IMRX | New Coverage | Buy (N/A) |
30.43 (2.90) |
-90.47% | Details | |
| 8/11/2021 | Moderna | MRNA | Maintain | Hold (N/A) |
|
Details | ||
| 8/9/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2021 | Moderna | MRNA | Maintain | Hold (N/A) |
|
Details | ||
| 7/26/2021 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 7/15/2021 | Moderna | MRNA | Maintain | Hold (N/A) |
|
Details | ||
| 7/7/2021 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 6/23/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 6/16/2021 | Moderna | MRNA | Maintain | Hold (N/A) |
|
Details | ||
| 6/14/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 6/11/2021 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2021 | Prothena Corp | PRTA | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 6/4/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2021 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2021 | ALX Oncology | ALXO | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2021 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 4/30/2021 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2021 | Kodiak Sciences Inc. | KOD | Maintain | Buy (N/A) |
|
Details | ||
| 4/26/2021 | Fate Therapeutics | FATE | New Coverage | Buy (N/A) |
85.34 (5.04) |
-94.09% | Details | |
| 4/20/2021 | Nuvation Bio Inc | NUVB | Maintain | Buy (N/A) |
|
Details | ||
| 4/19/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 4/12/2021 | Immunocore Holdings | IMCR | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2021 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2021 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 3/22/2021 | Odonate Therapeutics | ODT | Downgrade | Hold (Buy) |
19.03 (1.12) |
-94.11% | Details | |
| 3/18/2021 | Olema Pharmaceuticals | OLMA | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2021 | Beam Inc | BEAM | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2021 | Prothena Corp | PRTA | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2021 | Nuvation Bio Inc | NUVB | New Coverage | Buy (N/A) |
10.50 (2.58) |
-75.43% | Details | |
| 3/2/2021 | Morphic Therapeutic | MORF | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2021 | Immunocore Holdings | IMCR | New Coverage | Buy (N/A) |
48.36 (54.74) |
13.19% | Details | |
| 3/2/2021 | FibroGen | FGEN | Downgrade | Hold (Buy) |
50.03 (1.17) |
-97.66% | Details | |
| 2/18/2021 | Moderna | MRNA | Maintain | Hold (N/A) |
|
Details | ||
| 2/12/2021 | Esperion Therapeutics | ESPR | Downgrade | Hold (Buy) |
30.74 (1.87) |
-93.92% | Details | |
| 2/8/2021 | Zai Lab | ZLAB | New Coverage | Buy (N/A) |
177.52 (14.22) |
-91.99% | Details | |
| 2/5/2021 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 2/3/2021 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/25/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 1/14/2021 | Moderna | MRNA | Maintain | Hold (N/A) |
|
Details | ||
| 1/14/2021 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2021 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/29/2020 | Sigilon Therapeutics | SGTX | New Coverage | Buy (N/A) |
41.20 (22.47) |
-45.46% | Details | |
| 12/21/2020 | Esperion Therapeutics | ESPR | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2020 | Cerevel Therapeutics | CERE | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2020 | Assembly Biosciences | ASMB | Maintain | Hold (N/A) |
|
Details | ||
| 12/21/2020 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2020 | ALX Oncology | ALXO | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2020 | Moderna | MRNA | Downgrade | Hold (Buy) |
155.07 (102.00) |
-34.22% | Details | |
| 12/14/2020 | Olema pharmaceuticals | OLMA | New Coverage | Buy (N/A) |
45.73 (9.90) |
-78.35% | Details | |
| 11/23/2020 | Ceres | CERE | New Coverage | Buy (N/A) |
13.65 (42.14) |
208.72% | Details | |
| 11/10/2020 | Kodiak Sciences Inc. | KOD | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2020 | Assembly Biosciences | ASMB | Downgrade | Hold (Buy) |
16.04 (13.33) |
-16.9% | Details | |
| 11/4/2020 | Biogen | BIIB | Upgrade | Buy (Hold) |
247.01 (190.52) |
-22.87% | Details | |
| 11/3/2020 | Kronos Bio Inc. | KRON | New Coverage | Buy (N/A) |
28.09 (1.03) |
-96.33% | Details | |
| 10/29/2020 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 10/26/2020 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/12/2020 | Metacrine Inc. | MTCR | New Coverage | Buy (N/A) |
9.96 (0.49) |
-95.08% | Details | |
| 10/2/2020 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 10/2/2020 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 9/14/2020 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2020 | Amarin Corporation | AMRN | Maintain | Hold (N/A) |
|
Details | ||
| 8/27/2020 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 8/19/2020 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2020 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2020 | ALX Oncology | ALXO | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2020 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2020 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2020 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2020 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 7/21/2020 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 7/14/2020 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2020 | Moderna | MRNA | New Coverage | Buy (N/A) |
64.97 (102.00) |
57% | Details | |
| 7/1/2020 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 6/25/2020 | Intercept Pharmaceuticals | ICPT | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2020 | Amarin Corporation | AMRN | Maintain | Hold (N/A) |
|
Details | ||
| 5/7/2020 | Esperion Therapeutics | ESPR | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2020 | Acorda Therapeutics, Inc. | ACOR | Maintain | Hold (N/A) |
|
Details | ||
| 5/1/2020 | Gilead Sciences | GILD | Maintain | Neutral (N/A) |
|
Details | ||
| 4/30/2020 | Amarin Corporation | AMRN | Maintain | Hold (N/A) |
|
Details | ||
| 4/14/2020 | Amarin Corporation | AMRN | Maintain | Hold (N/A) |
|
Details | ||
| 4/13/2020 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 4/6/2020 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 4/3/2020 | Amarin Corporation | AMRN | Maintain | Hold (N/A) |
|
Details | ||
| 4/2/2020 | Amarin Corporation | AMRN | Maintain | Hold (N/A) |
|
Details | ||
| 3/31/2020 | Amarin Corporation | AMRN | Downgrade | Hold (Buy) |
13.24 (0.87) |
-93.43% | Details | |
| 3/20/2020 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2020 | Schrodinger | SDGR | New Coverage | Hold (N/A) |
46.38 (56.72) |
22.29% | Details | |
| 3/2/2020 | Beam Inc | BEAM | New Coverage | Buy (N/A) |
22.93 (24.31) |
6.02% | Details | |
| 2/24/2020 | Denali Therapeutics Inc. | DNLI | New Coverage | Buy (N/A) |
24.77 (16.60) |
-32.98% | Details | |
| 2/5/2020 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 1/16/2020 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 1/14/2020 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2019 | Epizyme | EPZM | Maintain | Buy (N/A) |
|
Details | ||
| 11/29/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 10/22/2019 | Biogen | BIIB | Maintain | Hold (N/A) |
|
Details | ||
| 9/12/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 8/22/2019 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 8/20/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 7/15/2019 | Akero Therapeutics | AKRO | New Coverage | Buy (N/A) |
18.37 (20.51) |
11.65% | Details | |
| 7/9/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 7/2/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 6/20/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 4/24/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2019 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2019 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2019 | Celgene | CELG | Maintain | Hold (N/A) |
|
Details | ||
| 2/27/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2019 | Spark Therapeutics | ONCE | Downgrade | Hold (Buy) |
51.56 (110.05) |
113.44% | Details | |
| 2/1/2019 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/1/2019 | Celgene | CELG | Downgrade | Hold (Buy) |
88.06 (108.24) |
22.92% | Details | |
| 12/20/2018 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2018 | Axovant Sciences | AXON | Upgrade | Buy (Hold) |
1.13 (297.59) |
26235.4% | Details | |
| 11/8/2018 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2018 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2018 | Rubius | RUBY | New Coverage | Buy (N/A) |
21.93 (0.08) |
-99.64% | Details |
